Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/15/2012WO2012151958A1 Low-toxic 3-pyrazole carboxylic acid amides, preparation methods and uses thereof in manufacture of medicines as cb1 receptor inhibitors
11/15/2012WO2012151704A1 Glycosaminoglycan-based therapy for the prevention/treatment of systemic sclerosis
11/15/2012WO2012151701A1 Methods for the treatment and diagnostic of pulmonary arterial hypertension
11/15/2012WO2012151687A1 Par1 inhibitors for use in the treatment or prevention of paramyxoviridae infections
11/15/2012WO2012151640A1 Methods for preparing naphthyridines
11/15/2012WO2012129394A9 Methods and compositions for the treatment of cancer
11/15/2012WO2012129324A9 6-substituted estradiol derivatives for use in remyelination of nerve axons
11/15/2012WO2012128587A3 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
11/15/2012WO2012128582A3 A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
11/15/2012WO2012128496A3 Pharmaceutical composition for preventing or treating asthma containing maackiain as an active ingredient
11/15/2012WO2012125981A3 Raf kinase inhibitors
11/15/2012WO2012125830A3 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
11/15/2012WO2012124966A3 Fentanyl transdermal patch
11/15/2012WO2012122106A3 Compositions and methods apc, creb, and bad pathways to assess and affect cancer
11/15/2012WO2012119051A9 Enhanced biodistribution of oligomers
11/15/2012WO2012109065A9 Treatment and prevention of cardiovascular disease and thrombosis
11/15/2012WO2012106534A3 Hiv integrase inhibitors
11/15/2012WO2012100109A3 Therapeutic eye drop comprising doxycycline and a stabilizer
11/15/2012WO2012099930A3 Flavonol compositions
11/15/2012WO2012099770A3 Diazeniumdiolate derivatives
11/15/2012WO2012095548A3 Dream inhibitors for treating neurodegenerative diseases
11/15/2012WO2012089622A3 Topical localized isoxazoline formulation
11/15/2012WO2012084852A3 Ectoparasiticidal active substance combinations
11/15/2012WO2012078831A3 Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity
11/15/2012WO2012078586A9 Pharmaceutical composition comprising nanog shrna, and method of usnig nanog shrna to treat cancer
11/15/2012WO2012068366A3 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
11/15/2012WO2012046250A8 Polymorphic forms of o-desmethyl-venlafaxine succinate
11/15/2012WO2012012184A3 Ophthalmic devices containing chemokine antagonists
11/15/2012WO2011120474A8 Method for inhibiting hiv replication in mammal and human cells
11/15/2012WO2011106729A3 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
11/15/2012US20120291159 Azoline Compounds for Combating Invertebrate Pests
11/15/2012US20120289606 Solid Formulations of Liquid Biologically Active Agents
11/15/2012US20120289605 Method for inducing udp-glucuronosyltransferase activity using pterostilbene
11/15/2012US20120289604 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
11/15/2012US20120289603 Enhanced bimatoprost ophthalmic solution
11/15/2012US20120289602 Pharmaceutical composition for treating or preventing burn injuries
11/15/2012US20120289601 Gastric Retained Gabapentin Dosage Form
11/15/2012US20120289600 Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production
11/15/2012US20120289598 Compositions including pyruvate for companion animals and methods of use thereof
11/15/2012US20120289597 Nitric oxide amino acid esters for the treatment of chronic pain
11/15/2012US20120289596 Dermatological Compositions Comprising a Fat or Oil of an Essential Fatty Acid Triglyceride
11/15/2012US20120289595 Novel biarylamide derivative and compositions containing the derivative as an active ingredient
11/15/2012US20120289594 Oral dosage form
11/15/2012US20120289593 Methods for risk assessment, treating, and diagnosing myocardial infarction
11/15/2012US20120289592 Ercc1 gene expression level is associated with clinical outcomes in esophageal cancer patients
11/15/2012US20120289591 Antimicrobial Compositions Containing Free Fatty Acids
11/15/2012US20120289590 Hair cosmetic composition
11/15/2012US20120289589 Treatment Of Immune Dysregulation Using Cannabinoid Derivatives
11/15/2012US20120289588 Lipase Inhibitors for the Treatment of Pancreatitis and Organ Failure
11/15/2012US20120289587 Compounds that modulate intracellular calcium
11/15/2012US20120289586 SDF-1 Delivery For Treating Ischemic Tissue
11/15/2012US20120289585 SDF-1 Delivery For Treating Ischemic Tissue
11/15/2012US20120289584 Compositions comprising cationic amphiphiles and colipids for delivering therapeutic molecules
11/15/2012US20120289583 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
11/15/2012US20120289582 Methods for diagnosing and treating a pathology associated with a synonymous mutation occuring within a gene of interest
11/15/2012US20120289581 Diagnostic, prognostic and therapeutic uses of long non-coding rnas for cancer and regenerative medicine
11/15/2012US20120289580 Antisense modulation of ptp1b expression
11/15/2012US20120289579 Impaired wound healing compositions and treatments
11/15/2012US20120289578 Use of rna interference for treating or reducing pain
11/15/2012US20120289577 Composition for treating or preventing hearing loss comprising naphthoquinone-based compounds
11/15/2012US20120289576 Process for Forming Amorphous Atorvastatin
11/15/2012US20120289575 Topical antimicrobial compositions
11/15/2012US20120289574 Hydrate crystals
11/15/2012US20120289573 Methods for treatment with bucindolol based on genetic targeting
11/15/2012US20120289572 Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes
11/15/2012US20120289571 Polymeric conjugates of aromatic amine containing compounds including releasable urea linker
11/15/2012US20120289570 Compositions and methods for treating and/or preventing cancer by inhibiting fatty acid binding proteins
11/15/2012US20120289569 Inhibitors of ubiquitin e1
11/15/2012US20120289568 Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289567 Combinations of darifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289566 Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289565 Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289564 Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289563 Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289562 Combinations of darifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289561 Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289560 Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289559 Method for producing fine powder and the fine powder produced by the same
11/15/2012US20120289558 Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
11/15/2012US20120289557 Protein Synthesis Required for Long-Term Memory is Induced by PKC Activation on Days Preceding Associative Learning
11/15/2012US20120289556 Methods for Treating Conditions Caused by Higher-Than-Normal Dopaminergic Activity In Basal Ganglia
11/15/2012US20120289555 Novel S-Nitrosoglutathione Reductase Inhibitors
11/15/2012US20120289554 4-dimethylaminobutyric acid derivatives
11/15/2012US20120289553 Oral liquid pharmaceutical composition of nifedipine
11/15/2012US20120289552 Aryl ureas with angiogenesis inhibiting activity
11/15/2012US20120289551 Mineralocorticoid receptor antagonists
11/15/2012US20120289550 Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
11/15/2012US20120289549 New hexahydropyrroloimidazolone compounds
11/15/2012US20120289548 Oligomer-opioid agonist conjugates
11/15/2012US20120289547 Combinations of propiverine and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289546 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine
11/15/2012US20120289545 Maleate Salts of (E)-N--4-(Dimethylamino)-2-Butenamide and Crystalline Forms Thereof
11/15/2012US20120289544 Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289543 Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289542 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
11/15/2012US20120289541 Methods and compositions for applying moxifloxacin to the ear
11/15/2012US20120289540 Kinase inhibitors useful for the treatment of proliferative diseases
11/15/2012US20120289539 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289538 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
11/15/2012US20120289537 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
1 ... 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 ... 7860